Home > > > > > Report Detail

Herpes Simplex - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's ‘Herpes Simplex Virus (HSV) Infections- Epidemiology Forecast to 2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of HSV infections in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered

- The United States

- EU5 (Germany, France, Italy, Spain and the United Kingdom)

- Japan

Study Period: 2016-2028

HSV infections Epidemiology

The HSV Infections epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for HSV Infections are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

HSV Infections Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, prevalent cases by types (Genital Herpes and Herpes Labialis), diagnosed prevalence] of HSV infections in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2028.

The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to DelveInsight, total prevalent population of HSV infections in 7 major markets was estimated to be about 228,552,199 in 2016.

Report Scope

- The report covers detailed overview of HSV infections explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- The report provides the insight about the historical and forecasted patient pool of HSV infections in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Report assesses the disease risk and burden and highlights the unmet needs of the disease

- The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population

- The report provides the segmentation of the disease epidemiology by types and diagnosed prevalent cases of HSV infections in 7MM

Key strengths

- 10 Year Forecast of HSV infections epidemiology

- 7MM Coverage

- Total Prevalent Cases of HSV infections

- Prevalent Cases according to segmentation: HSV infections by clinical types (Genital Herpes and Herpes Labialis) in 7MM

- Diagnosed cases of HSV infections

Key assessments

- Patient Segmentation

- Disease Risk & Burden

- Risk of disease by the segmentation

- Factors driving growth in a specific patient population

Herpes Simplex - Epidemiology Forecast to 2028

Table of Contents

1. Key Insights
2. Disease Background and Overview: Herpes Simplex Virus (HSV)
2.1. Introduction
2.2. Stages of Herpes infection
2.3. Clinical manifestations
2.4. Risk Factors
2.5. Disease Causes
2.6. HSV-Symptoms
2.7. Pathogenesis
2.8. HSV Diagnosis
3. Epidemiology and Patient Population
4. Key Findings
4.1. Disease Definition
4.2. Population and Forecast Parameters
4.3. 7MM Prevalent Population of Herpes Simplex Virus (HSV)
4.4. 7MM Type-Specific Prevalent Population of Herpes Simplex Virus (HSV)
5. Country Wise-Epidemiology of Herpes Simplex Virus (HSV)
5.1. United States
5.1.1. Prevalent Population of HSV in the United States
5.1.2. Type-Specific HSV Prevalence in the United States
5.1.3. Diagnosed Cases of HSV in the United States
5.2. Germany
5.2.1. Prevalent Population of HSV in Germany
5.2.2. Type-Specific HSV Prevalence in Germany
5.2.3. Diagnosed Cases of HSV in Germany
5.3. France
5.3.1. Prevalent Population of HSV in France
5.3.2. Type-Specific HSV Prevalence in France
5.3.3. Diagnosed Cases of HSV in France
5.4. Italy
5.4.1. Prevalent Population of HSV in Italy
5.4.2. Type Specific HSV prevalence in Italy
5.4.3. Diagnosed cases of HSV in Italy
5.5. Spain
5.5.1. Prevalent Population of HSV in Spain
5.5.2. Type Specific HSV prevalence in Spain
5.5.3. Diagnosed cases of HSV in Spain
5.6. United Kingdom
5.6.1. Prevalent cases of HSV in the UK
5.6.2. Type Specific HSV prevalence in the UK
5.6.3. Diagnosed cases of HSV in the UK
5.7. Japan
5.7.1. Prevalent cases of HSV in Japan
5.7.2. Type Specific HSV prevalence in Japan
5.7.3. Diagnosed cases of HSV in Japan
6. Market Drivers of HSV
7. Market Barriers of HSV
8. Appendix
9. Report Methodology
9.1. Sources Used
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight

List of Tables

Table 1: Prevalent Population of HSV in the 7MM (2016-2028)
Table 2: 7MM Type-Specific Prevalent Population of HSV (2016-2028)
Table 3: Prevalent Population of HSV in the United States (2016-2028)
Table 4: Type-Specific HSV Prevalence in the United States (2016-2028)
Table 5: Diagnosed Cases of HSV in the United States (2016-2028)
Table 6: Prevalent Population of HSV in Germany (2016-2028)
Table 7: Type-Specific HSV Prevalence in Germany (2016-2028)
Table 8: Diagnosed Cases of HSV in Germany (2016-2028)
Table 9: Prevalent Population of HSV in France (2016-2028)
Table 10: Type-Specific HSV Prevalence in France (2016-2028)
Table 11: Diagnosed Cases of HSV in France (2016-2028)
Table 12: Prevalent Population of HSV in Italy (2016-2028)
Table 13: Type-Specific HSV Prevalence in Italy (2016-2028)
Table 14: Diagnosed Cases of HSV in Italy (2016-2028)
Table 15: Prevalent Population of HSV in Spain (2016-2028)
Table 16: Type-Specific HSV Prevalence in Spain (2016-2028)
Table 17: Diagnosed Cases of HSV in Spain (2016-2028)
Table 18: Prevalent Population of HSV in the UK (2016-2028)
Table 19: Type-Specific HSV Prevalence in the UK (2016-2028)
Table 20: Diagnosed Cases of HSV in the UK (2016-2028)
Table 21: Prevalent Population of HSV in Japan (2016-2028)
Table 22: Type-Specific HSV Prevalence in Japan (2016-2028)
Table 23: Diagnosed Cases of HSV in Japan (2016-2028)

List of Figures

Figure 1: Stages of Herpes infection
Figure 2: Clinical manifestations of Herpes infection
Figure 3: Risk factors associated with Herpes Simplex
Figure 4: Blisters
Figure 5: (a) Primary infection (b) Recurrent infection
Figure 6: Life Cycle of HSV infection
Figure 7: Establishment of primary infection
Figure 8: Prevalent Population of HSV in the 7MM (2016-2028)
Figure 9: 7MM Type-Specific Prevalent Population of HSV (2016-2028)
Figure 10: Prevalent Population of HSV in the United States (2016-2028)
Figure 11: Type-specific HSV Prevalence in the United States (2016-2028)
Figure 12: Diagnosed Cases of HSV in the United States (2016-2028)
Figure 13: Prevalent Population of HSV in Germany (2016-2028)
Figure 14: Type-specific HSV Prevalence in Germany (2016-2028)
Figure 15: Diagnosed Cases of HSV in Germany (2016-2028)
Figure 16: Prevalent Population of HSV in France (2016-2028)
Figure 17: Type-specific HSV Prevalence in France (2016-2028)
Figure 18: Diagnosed Cases of HSV in France (2016-2028)
Figure 19: Prevalent Population of HSV in Italy (2016-2028)
Figure 20: Type-specific HSV Prevalence in Italy (2016-2028)
Figure 21: Diagnosed Cases of HSV in Italy (2016-2028)
Figure 22: Prevalent Population of HSV in Spain (2016-2028)
Figure 23: Type-specific HSV Prevalence in Spain (2016-2028)
Figure 24: Diagnosed Cases of HSV in Spain (2016-2028)
Figure 25: Prevalent Population of HSV in the UK (2016-2028)
Figure 26: Type-specific HSV Prevalence in the UK (2016-2028)
Figure 27: Diagnosed Cases of HSV in the UK (2016-2028)
Figure 28: Prevalent Population of HSV in Japan (2016-2028)
Figure 29: Type-specific HSV Prevalence in Japan (2016-2028)
Figure 30: Diagnosed Cases of HSV in Japan (2016-2028)
  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs